Inflammation in Vein Graft Disease

被引:74
|
作者
de Vries, Margreet R. [1 ]
Quax, Paul H. A. [1 ]
机构
[1] Leiden Univ, Med Ctr, Einthoven Lab Expt Vasc Med, Dept Surg, Leiden, Netherlands
来源
FRONTIERS IN CARDIOVASCULAR MEDICINE | 2018年 / 5卷
关键词
cardiovascular disease; bypass graft; saphenous vein; vein graft disease; inflammation; innate immunity; atherosclerosis; SMOOTH-MUSCLE-CELLS; INTERNAL MAMMARY ARTERY; PLASMINOGEN-ACTIVATOR INHIBITOR-1; SUPPRESSES NEOINTIMA FORMATION; CIRCULATING PROGENITOR CELLS; COMPLEMENT FACTOR C5A; TOUCH SAPHENOUS-VEIN; MARROW-DERIVED CELLS; FACTOR-KAPPA-B; INTIMAL HYPERPLASIA;
D O I
10.3389/fcvm.2018.00003
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Bypass surgery is one of the most frequently used strategies to revascularize tissues downstream occlusive atherosclerotic lesions. For venous bypass surgery the great saphenous vein is the most commonly used vessel. Unfortunately, graft efficacy is low due to the development of vascular inflammation, intimal hyperplasia and accelerated atherosclerosis. Moreover, failure of grafts leads to significant adverse outcomes and even mortality. The last couple of decades not much has changed in the treatment of vein graft disease (VGD). However, insight is the cellular and molecular mechanisms of VGD has increased. In this review, we discuss the latest insights on VGD and the role of inflammation in this. We discuss vein graft pathophysiology including hemodynamic changes, the role of vessel wall constitutions and vascular remodeling. We show that profound systemic and local inflammatory responses, including inflammation of the perivascular fat, involve both the innate and adaptive immune system.
引用
收藏
页数:13
相关论文
共 50 条
  • [31] Chronic Kidney Disease Augments Vein Graft Disease Through Interleukin-9-dependent Mechanisms
    Zhang, Lisheng
    Brian, Leigh
    Mattocks, Natalie K.
    Gurley, Susan B.
    Freedman, Neil J.
    CIRCULATION, 2015, 132
  • [32] The protective role of Toll-like receptor 3 and type-I interferons in the pathophysiology of vein graft disease
    Simons, K. H.
    de Vries, M. R.
    Peters, H. A. B.
    Hamming, J. F.
    Jukema, J. W.
    Quax, P. H. A.
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2018, 121 : 16 - 24
  • [33] Mineralocorticoid receptor antagonism inhibits vein graft remodeling in mice
    Ehsan, Afshin
    McGraw, Adam P.
    Aronovitz, Mark J.
    Galayda, Carol
    Conte, Michael S.
    Karas, Richard H.
    Jaffe, Iris Z.
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2013, 145 (06) : 1642 - +
  • [34] Late Saphenous Vein Graft Disease: Cut to the Chase
    Engin, Mesut
    Guvenc, Orhan
    Aydin, Ufuk
    Ata, Yusuf
    ANGIOLOGY, 2023, 74 (06) : 602 - 603
  • [35] The Value of Inflammation indexes in Predicting Patency of Saphenous Vein Grafts in Patients With Coronary Artery Bypass Graft Surgery
    Aydin, Cihan
    Engin, Mesut
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (07)
  • [36] PATHOPHYSIOLOGY OF VEIN GRAFT FAILURE - A REVIEW
    DAVIES, MG
    HAGEN, PO
    EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY, 1995, 9 (01) : 7 - 18
  • [37] Gene Therapy for Vein Graft Failure
    Wang, Xiao-Wen
    Zhao, Xing-Ji
    Xiang, Xiao-Yong
    JOURNAL OF CARDIAC SURGERY, 2013, 28 (02) : 144 - 147
  • [38] Pioglitazone preserves vein graft integrity in a rat aortic interposition model
    Chen, Zhi
    Hasegawa, Tomomi
    Tanaka, Akiko
    Okita, Yutaka
    Okada, Kenji
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2010, 140 (02) : 408 - e1
  • [39] Vein graft failure: current clinical practice and potential for gene therapeutics
    Wan, S.
    George, S. J.
    Berry, C.
    Baker, A. H.
    GENE THERAPY, 2012, 19 (06) : 630 - 636
  • [40] Aortocoronary saphenous vein graft disease - Pathogenesis, predisposition, and prevention
    Motwani, JG
    Topol, EJ
    CIRCULATION, 1998, 97 (09) : 916 - 931